Follistatin 344
Follistatin 344
Myostatin inhibitor peptide. Blocks the protein that limits muscle growth, unlocking enhanced anabolic potential beyond genetic ceilings.
Save 10% when you pay in crypto (BTC · ETH · USDT)
Free shipping on orders over $250
Research use only. Products are not intended for human consumption.
We accept
Interac e-Transfer · BTC · ETH · USDT crypto −10%
How ordering works
- 01Place your order — no payment is taken on this site.
- 02Payment instructions arrive by email reply (Interac e-Transfer or crypto).
- 03Paid before 4 PM EST → same-day dispatch with tracking number.
Refrigerated SKU? Ships in an insulated cold-pack mailer. You receive a packaging photograph within 4 hours of dispatch.
- Janoshik verified — per-batch third-party purity testing
- Discreet — plain packaging, no brand markings
- Cold-pack mailer for refrigerated SKUs
- Refund + retest if a batch fails purity
Complete protocols
Build your stack
Stacks that include Follistatin 344 — protocol components priced together, bulk savings applied automatically.
At a glance
At a glance
- Concentration
- 1mg
- Purity
- 99.5%+
- Route
- Subcutaneous injection
- Storage
- Lyophilized: room temperature, desiccated. Reconstituted: 2–8°C, ≤30 days.
Compound profile
Follistatin 344 is a single-domain glycoprotein consisting of 344 amino acids that functions as the body's primary endogenous inhibitor of myostatin — the protein that sets the genetic ceiling on muscle growth. Myostatin (also called GDF-8) is a member of the TGF-beta superfamily and acts as a powerful negative regulator of skeletal muscle mass. Animals with natural myostatin mutations (Belgian Blue cattle, Bully Whippets) exhibit dramatic muscular hypertrophy. Follistatin binds directly to myostatin with high affinity, neutralizing its activity and effectively removing the biological brake on muscle growth.
Follistatin 344 is a single-domain glycoprotein consisting of 344 amino acids that functions as the body's primary endogenous inhibitor of myostatin — the protein that sets the genetic ceiling on muscle growth. Myostatin (also called GDF-8) is a member of the TGF-beta superfamily and acts as a powerful negative regulator of skeletal muscle mass. Animals with natural myostatin mutations (Belgian Blue cattle, Bully Whippets) exhibit dramatic muscular hypertrophy. Follistatin binds directly to myostatin with high affinity, neutralizing its activity and effectively removing the biological brake on muscle growth.
Follistatin's mechanism is elegantly direct: it binds to myostatin in the extracellular space, forming a Follistatin-myostatin complex that prevents myostatin from binding to its receptor (activin receptor type IIB, ActRIIB). This neutralization removes the anti-anabolic signal that myostatin constitutively delivers to muscle tissue, resulting in enhanced muscle protein synthesis, satellite cell proliferation, and myofiber hypertrophy. Importantly, Follistatin also binds and neutralizes activin A, another TGF-beta family member with muscle-inhibiting properties, providing a dual anti-catabolic effect. The 344-amino-acid isoform (as opposed to the shorter 315 isoform) has greater heparin-binding affinity, which concentrates it near cell surfaces and may improve its local activity at muscle tissue.
Research on follistatin demonstrates significant increases in skeletal muscle mass, strength, and satellite cell activity. Gene therapy studies using follistatin vectors have produced the most dramatic results: non-human primate studies showed sustained increases in muscle mass and strength persisting for years. Recombinant follistatin research shows dose-dependent increases in muscle protein synthesis and reductions in myostatin-mediated catabolic signaling. The compound has also generated interest in muscular dystrophy research, where myostatin inhibition can partially compensate for the progressive muscle loss characteristic of the disease.
Follistatin 344 is suited for advanced researchers investigating myostatin biology, genetic limits on muscle growth, muscle wasting conditions, and the TGF-beta signaling pathway. It represents the most direct approach to removing the body's endogenous ceiling on muscular development.
Reconstitute the 1mg vial carefully with 1ml bacteriostatic water — Follistatin 344 is a large, complex glycoprotein that requires gentle handling. Roll the vial to dissolve; do not shake. Administer via subcutaneous injection, typically 100-200mcg per day. Protocols typically run 10-30 days, with researchers noting the most pronounced effects during the first 10-14 days. Follistatin 344 has a relatively short half-life of several hours, supporting once-daily dosing. Store at 2-8C after reconstitution. Lyophilized powder should be stored at -20C. Due to the compound's complexity and cost, precise reconstitution and careful storage are essential.
---
## Nootropics & Cognitive
How to use
Injection technique, site rotation, and frequency guidance. Typical protocols split the weekly dose into 2 injections.
Follistatin 344 is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water (BAC water) before use in a research setting.
- Clean the BAC water vial stopper and the peptide vial stopper with an alcohol swab. Allow to dry.
- Draw the required volume of BAC water into a sterile syringe (typically 1–3 mL depending on target concentration).
- Angle the needle so the water runs down the inside wall of the peptide vial. Avoid dispensing directly onto the powder.
- Do not shake. Gently swirl or roll until fully dissolved. Vigorous shaking can denature peptides.
- Refrigerate reconstituted solution at 2–8°C. Most reconstituted peptides are stable 14–30 days depending on compound.
Target concentration determines drawing volume. For dosing math, consult the dosing math guide.
Independent lab verification
Research disclaimer
For research and laboratory use only. Not for human or veterinary consumption. Nova Pharma sells to qualified researchers of legal age and ships to Canadian addresses only. See disclaimer and terms.
At a glance
At a glance
- Concentration
- 1mg
- Purity
- 99.5%+
- Route
- Subcutaneous injection
- Storage
- Lyophilized: room temperature, desiccated. Reconstituted: 2–8°C, ≤30 days.
Compound profile
Follistatin 344 is a single-domain glycoprotein consisting of 344 amino acids that functions as the body's primary endogenous inhibitor of myostatin — the protein that sets the genetic ceiling on muscle growth. Myostatin (also called GDF-8) is a member of the TGF-beta superfamily and acts as a powerful negative regulator of skeletal muscle mass. Animals with natural myostatin mutations (Belgian Blue cattle, Bully Whippets) exhibit dramatic muscular hypertrophy. Follistatin binds directly to myostatin with high affinity, neutralizing its activity and effectively removing the biological brake on muscle growth.
Follistatin 344 is a single-domain glycoprotein consisting of 344 amino acids that functions as the body's primary endogenous inhibitor of myostatin — the protein that sets the genetic ceiling on muscle growth. Myostatin (also called GDF-8) is a member of the TGF-beta superfamily and acts as a powerful negative regulator of skeletal muscle mass. Animals with natural myostatin mutations (Belgian Blue cattle, Bully Whippets) exhibit dramatic muscular hypertrophy. Follistatin binds directly to myostatin with high affinity, neutralizing its activity and effectively removing the biological brake on muscle growth.
Follistatin's mechanism is elegantly direct: it binds to myostatin in the extracellular space, forming a Follistatin-myostatin complex that prevents myostatin from binding to its receptor (activin receptor type IIB, ActRIIB). This neutralization removes the anti-anabolic signal that myostatin constitutively delivers to muscle tissue, resulting in enhanced muscle protein synthesis, satellite cell proliferation, and myofiber hypertrophy. Importantly, Follistatin also binds and neutralizes activin A, another TGF-beta family member with muscle-inhibiting properties, providing a dual anti-catabolic effect. The 344-amino-acid isoform (as opposed to the shorter 315 isoform) has greater heparin-binding affinity, which concentrates it near cell surfaces and may improve its local activity at muscle tissue.
Research on follistatin demonstrates significant increases in skeletal muscle mass, strength, and satellite cell activity. Gene therapy studies using follistatin vectors have produced the most dramatic results: non-human primate studies showed sustained increases in muscle mass and strength persisting for years. Recombinant follistatin research shows dose-dependent increases in muscle protein synthesis and reductions in myostatin-mediated catabolic signaling. The compound has also generated interest in muscular dystrophy research, where myostatin inhibition can partially compensate for the progressive muscle loss characteristic of the disease.
Follistatin 344 is suited for advanced researchers investigating myostatin biology, genetic limits on muscle growth, muscle wasting conditions, and the TGF-beta signaling pathway. It represents the most direct approach to removing the body's endogenous ceiling on muscular development.
Reconstitute the 1mg vial carefully with 1ml bacteriostatic water — Follistatin 344 is a large, complex glycoprotein that requires gentle handling. Roll the vial to dissolve; do not shake. Administer via subcutaneous injection, typically 100-200mcg per day. Protocols typically run 10-30 days, with researchers noting the most pronounced effects during the first 10-14 days. Follistatin 344 has a relatively short half-life of several hours, supporting once-daily dosing. Store at 2-8C after reconstitution. Lyophilized powder should be stored at -20C. Due to the compound's complexity and cost, precise reconstitution and careful storage are essential.
---
## Nootropics & Cognitive
How to use
Injection technique, site rotation, and frequency guidance. Typical protocols split the weekly dose into 2 injections.
Follistatin 344 is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water (BAC water) before use in a research setting.
- Clean the BAC water vial stopper and the peptide vial stopper with an alcohol swab. Allow to dry.
- Draw the required volume of BAC water into a sterile syringe (typically 1–3 mL depending on target concentration).
- Angle the needle so the water runs down the inside wall of the peptide vial. Avoid dispensing directly onto the powder.
- Do not shake. Gently swirl or roll until fully dissolved. Vigorous shaking can denature peptides.
- Refrigerate reconstituted solution at 2–8°C. Most reconstituted peptides are stable 14–30 days depending on compound.
Target concentration determines drawing volume. For dosing math, consult the dosing math guide.
Independent lab verification
Research disclaimer
For research and laboratory use only. Not for human or veterinary consumption. Nova Pharma sells to qualified researchers of legal age and ships to Canadian addresses only. See disclaimer and terms.
Read the research
Reference articles from the lab covering this compound.
best of
Best Peptides for Muscle Growth 2026: From GH Secretagogues to Growth Factors
Best peptides for muscle growth in 2026 ranked by mechanism: GH secretagogues, growth factors, and myostatin inhibitors. Protocols for natural lifters, bodybuilders on AAS, and injury-plagued athletes.
compound guides
Follistatin 344: The Myostatin Blocker for Extreme Muscle Growth
Follistatin 344 inhibits myostatin — the gene that limits muscle growth. Learn how this peptide works, realistic expectations vs. gene therapy, dosing protocols, and how it compares to YK-11 for Canadian researchers.
Complete the protocol
Reconstitution Kit — Standard
30ml bac water · 10 syringes · mixing syringe · swabs
4.9
